The Front Room — a clinical regulatory commons
RSS
REGULATION 2020 revision

Good Clinical Practice for Drug Clinical Trials (2020 Revision)

No. 57 National Medical Products Administration
ABSTRACT — EDITORS' SUMMARY

The current NMPA GCP regulation. Closely aligned with ICH E6 with additional emphasis on documentation traceability and sponsor decision evidence.

EMBEDDED PDF
Page of —
DownloadView on NMPA ↗
Loading PDF…
METADATA
TypeREGULATION
Year2020
Version2020 revision
StatusCurrent
FormatPDF
Pages70
Size1.4 MB
Last reviewedJUL 2020
SOURCE
PDF · CANONICAL LINK https://clinregs.niaid.nih.gov/sites/default/files/documents/china/NMPA-GCP-No57-2020_Google-Translation.pdf ↗
RELATED · SAME AUTHORITY
NMPA NMPA Announcement No. 125 of 2025
NMPA Announcement on Adoption of ICH E6(R3) Good Clinical Practice Guideline
NOTICE 2025
NMPA CDE, November 2025
Guiding Principles for Computerized Systems and Electronic Data in Drug Clinical Trials (Draft for Comment)
GUIDANCE 2025
NMPA 2025
Good Clinical Practice for Drugs (2025 Revision — Draft for Comments)
REGULATION 2025
NMPA 2025
Inspection Checkpoints and Judging Principles for Drug Clinical Trials
INSPECTION PROCEDURE 2025
NMPA No. 31 of 2024
Technical Guidelines for Evaluation of the Relevance of Adverse Events in Drug Clinical Trials
GUIDANCE 2024